Home  >  Research  >  Labs  >  Cancer and cell biology division


The Cancer and cell biology division is co-led by Professor Ruth Ganss and Associate Professor Andrew Redfern.

Perkins researchers have made major discoveries in the field of cancer including uncovering the SLIRP gene which controls hormone production in breast and prostate cancers, the tumour suppressor gene HLS5 and a process for normalising blood vessels in tumours to allow more effective absorption of cancer-combating drugs. Detailed information about our cancer laboratories and programs is below.

Professor Ruth Ganss

Professor Ruth Ganss

Scientific Head, Cancer and cell biology division

Read more
Professor Andrew Redfern

Professor Andrew Redfern

Clinical Head, Cancer and cell biology division

Read more


Cancer epigenetics

Cell signaling

Laboratory for
cancer medicine

Liver disease and

Systems biology and

Targeted drug delivery,
imaging and therapy




Boost for liver cancer patients with new $10.8 million world-class research centre

Patients with primary liver cancer will benefit from a new $10.8 million research centre established with a $5 million Cancer Research Trust grant and $5.8 million from Minderoo Foundation, Curtin…

Read More

Ground-breaking COVID-19 Vaccine Trial Underway in Perth: First Participants Dosed After Thousands Register

An unprecedented number of people signed up to help in the fight against COVID-19 with more than 4000 registering for a ground-breaking vaccine trial at the Perkins trials facility, Linear…

Read More

Improving treatment for severe leukaemia

Researchers from the Harry Perkins Institute of Medical Research have collaborated on a major project to help in the development of a new and improved way to treat the poor-prognosis…

Read More

Help fund groundbreaking research.

Donate Now